Salvage therapy for multidrug-resistant tuberculosis

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Gut bacterial microbiota and obesity
I.J. Schalk  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
Varicella vaccination: a laboured take-off
S. Wagenpfeil, A. Neiss, K. Banz, P. Wutzler 
Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources  N. Singh,
Herpes zoster in non-hospitalized children
Migrant health—a cause for concern?
Clinical characteristics of Haemophilus influenzae meningitis in Denmark in the post- vaccination era  T.I. Pedersen, M. Howitz, C. Østergaard  Clinical.
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
J.-P. Van geertruyden  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Nocardiosis in Quebec, Canada, 1988–2008
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Surveillance of Legionnaires’ disease in Austria
Analysis of intracellular human immunodeficiency virus (HIV)-1 drug resistance mutations in multi-failed HIV-1-infected patients treated with a salvage.
Vector control: a cornerstone in the malaria elimination campaign
Characterization of Mycobacterium tuberculosis isolated from cancer patients with suspected tuberculosis infection in Egypt: identification, prevalence,
Training for the infectious diseases speciality in Norway
E.C. Böttger  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
Performance of hepatitis C virus (HCV) direct-acting antivirals in clinical trials and daily practice  J.E. Arends, P.A.M. Kracht, A.I.M. Hoepelman  Clinical.
S. Borrell, S. Gagneux  Clinical Microbiology and Infection 
Salvage therapy for multidrug-resistant tuberculosis
B. Y. Lee, Z. S. Wettstein, S. M. McGlone, R. R. Bailey, C. A
Elements of design: the knowledge on which we build
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Metagenomics and probiotics
Laboratory diagnosis of Clostridium difficile disease
A case of pleurisy associated with antibodies to Rickettsia conorii
Recent developments in staphylococcal scalded skin syndrome
The practice of travel medicine in Europe
Continuous high-dose vancomycin combination therapy for methicillin-resistant staphylococcal prosthetic hip infection: a prospective cohort study  V.
T.M. File  Clinical Microbiology and Infection 
Update on antifungal resistance in Aspergillus and Candida
Antibacterial drug discovery in the 21st century
Abstracts cont. Clinical Microbiology and Infection
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Antimicrobial drug development – the past, the present, and the future
An after-hours clinical liaison blood culture service—is it worth it?
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Changing pattern of candidaemia 2001–2006 and use of antifungal therapy at the University Hospital of Vienna, Austria  E. Presterl, F. Daxböck, W. Graninger,
W. Eugene Sanders, Christine C. Sanders 
Tuberculosis in HIV-infected patients: a comprehensive review
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
The atypical pneumonias: clinical diagnosis and importance
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
Modelling during an emergency: the 2009 H1N1 influenza pandemic
Carratalà J.   Clinical Microbiology and Infection 
B.A. Cunha  Clinical Microbiology and Infection 
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
New patterns of HIV-1 resistance during HAART
Joshua P. Metlay, Daniel E. Singer  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Comparative study of pediculicidal effect of medical plants
CMI readers' survey Clinical Microbiology and Infection
The future of diagnostic bacteriology
Presentation transcript:

Salvage therapy for multidrug-resistant tuberculosis K.J. Seung, M.C. Becerra, S.S. Atwood, F. Alcántara, C.A. Bonilla, C.D. Mitnick  Clinical Microbiology and Infection  Volume 20, Issue 5, Pages 441-446 (May 2014) DOI: 10.1111/1469-0691.12335 Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Cohort selection. Clinical Microbiology and Infection 2014 20, 441-446DOI: (10.1111/1469-0691.12335) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Number of drugs used in the salvage regimen (n = 213). Clinical Microbiology and Infection 2014 20, 441-446DOI: (10.1111/1469-0691.12335) Copyright © 2014 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.